Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure
Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.
top of page
Upload a PDF
Max File Size 15MB
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Clinical
Trials
- May 26
- 4 min
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons
. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...
- May 19
- 3 min
Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
- May 15
- 2 min
Sealonix raises $20 Million to develop sealants for abdominopelvic and orthopedic procedures
The PramStat patch builds on many years of research done by this experienced team, and now will move rapidly into clinical development.
- May 12
- 6 min
Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction
Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate
- May 11
- 3 min
Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology
DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.
- May 10
- 4 min
Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In Life Sciences
PBI's UltraShear™ Technology (UST™) platform is tailor-made to produce high-quality CBD nanoemulsions.
- May 3
- 4 min
Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials
We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum
- Apr 25
- 2 min
ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP
ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,
- Apr 19
- 2 min
Medical device company, BioVentrix closes on $48.5 million to improve cardiac function
BioVentrix is a medical device company focused on the development of less invasive therapies to treat the failing left ventricle.
- Apr 18
- 4 min
Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases
Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases
- Apr 14
- 4 min
Novo Holdings participates in $105 million funding in Alentis Therapeutics
Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.
- Apr 3
- 3 min
Orion is building a pharmaceutical research ecosystem using data and artificial intelligence
Artificial intelligence-guided use of data is a competitive advantage when developing new innovative medicines.
- Mar 30
- 3 min
Viking Therapeutics prices $250 Million public common stock offering
Viking Therapeutics is a clinical-stage biopharmaceutical company that is developing novel first-in-class or best-in-class therapies
- Mar 4
- 3 min
Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer
Prana Thoracic is developing the first minimally invasive, lung-sparing device for early intervention of suspicious pulmonary nodules.
- Mar 2
- 6 min
Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial
RADICAVA is administered in 28-day cycles by IV infusion for ALS.
- Feb 24
- 5 min
Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million
. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...
- Feb 13
- 2 min
Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services
- Feb 1
- 4 min
Panbela prices $15 million public offering
CPP-1X (eflornithine) is being developed as a single agent tablet or high dose power sachet for several indications including prevention...
- Jan 18
- 2 min
To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab
The company seeks to achieve U.S. regulatory approval for Bentracimab within the first-half of 2024.
- Jan 4
- 3 min
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea
Enrollment for the clinical trials is expected to begin in the second quarter of 2023
- Dec 27, 2022
- 2 min
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies
Under the agreement. Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze...
- Dec 22, 2022
- 4 min
University Hospitals Performs First Arthroscopic Surgeries in Ohio using ArthroFree Wireless Camera
Lazurite‘s ArthroFree is the first wireless surgical camera system to receive market clearance from the U.S. Food and Drug Administration...
- Nov 23, 2022
- 3 min
scPharmaceuticals Announces Pricing of $50 Million Public Offering
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...
- Nov 5, 2022
- 3 min
H.I.G. Capital acquires leading global clinical research organization Celerion
Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinic
- Oct 15, 2022
- 4 min
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development
The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.
- Oct 8, 2022
- 4 min
RadioMedix raises $40 million to advance its alpha therapy platform for oncology
Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.
- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus
“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.
- Sep 28, 2022
- 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome
Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.
- Sep 27, 2022
- 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects
Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.
- Sep 1, 2022
- 3 min
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease
OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .
- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials
For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.
- Aug 5, 2022
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy
Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.
- Aug 3, 2022
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.
- Jul 29, 2022
- 3 min
HempMy Pet and Tarleton University announce positive results of their study using CBD on horses
HempMy Pet, a division of HM Health, LLC, offers CBD-infused products for dogs, cats, and horses.
- Jul 11, 2022
- 3 min
FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100
Inflammation is a key feature in the pathogenesis of ARDS and the investigational product (IP) ALT-100 is an anti-inflammatory therapeutic..
- Jul 9, 2022
- 4 min
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology
There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA
- Jun 5, 2022
- 3 min
Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials
Imaging Endpoints is the world’s largest oncology-focused imaging CRO and has partnered with ImaginAb over the past decade.
- May 14, 2022
- 7 min
Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS
We continue to push the boundaries of innovation with RADICAVA ORS, an orally administered option allowing patients flexibility...
- May 7, 2022
- 2 min
Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial
Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories
- May 4, 2022
- 3 min
Four pharma solution providers launch Norstella to provide faster patient access to therapies
By launching Norstella, we’re taking the next step toward ensuring tha.t all patients have access to the therapies that they need
- Apr 15, 2022
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test
“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.
- Apr 7, 2022
- 2 min
ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS
"With the close of this funding we will continue the journey from concept to clinical use/"
- Mar 26, 2022
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform
Globally, liver cancers are the fourth most common cause of cancer-related death and ranked sixth in terms of annual incidence.
- Mar 24, 2022
- 3 min
Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic
Sen-Jam and KVK Tech will complete their phase II clinical trials or their oral COVID-19 drug, to have a finished product in 9-12 months.
- Mar 21, 2022
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics
“Cell therapies have become an essential modality in the oncology therapeutic arsenal and a priority for many biopharma companies.
- Mar 2, 2022
- 2 min
Alcami, the contract development and manufacturer adds formulation development laboratory
Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions
- Feb 28, 2022
- 4 min
Algernon Pharmaceuticals starts chronic kidney disease research program
Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds.
- Feb 19, 2022
- 2 min
Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma
Dizal has a portfolio of innovative therapies for the treatment of cancer, immunological diseases and chronic kidney diseases.
- Feb 14, 2022
- 5 min
Otsuka and Sunovlon start Phase 3 trials for a treatment for biopolar depression
Bipolar disorder affects approximately 12.6 million individuals in the United States and an estimated 29 million people worldwide.
bottom of page